USE OF ELECTROMAGNETIC WAVE ABSORBING MARKERS FOR THE AUTHENTICATION OF SECURITY DOCUMENTS USE OF ELECTROMAGNETIC WAVE ABSORBING MARKERS FOR THE AUTHENTICATION OF SECURITY DOCUMENTS
USE OF ELECTROMAGNETIC WAVE ABSORBING MARKERS FOR THE AUTHENTICATION OF SECURITY DOCUMENTS USE OF ELECTROMAGNETIC WAVE ABSORBING MARKERS FOR THE AUTHENTICATION OF SECURITY DOCUMENTS
USE OF ESSENTIAL OILS SUPERCRITICAL EXTRACTS AND AQUEOUS RESIDUES GENERATED DURING A PROCESS FOR OBTAINING ORGANIC EXTRACTS FROM THE ARTEMISIA ABSINTHIUM L PLANT USE OF ESSENTIAL OILS SUPERCRITICAL EXTRACTS AND AQUEOUS RESIDUES GENERATED DURING A PROCESS FOR OBTAINING ORGANIC EXTRACTS FROM THE ARTEMISIA ABSINTHIUM L PLANT
USE OF ESTERS DERIVED FROM GALLIC ACID AS ANTIVIRALS USE OF ESTERS DERIVED FROM GALLIC ACID AS ANTIVIRALS
USE OF ESTERS DERIVED FROM GALLIC ACID AS ANTIVIRALS USE OF ESTERS DERIVED FROM GALLIC ACID AS ANTIVIRALS
USE OF IGF AS A REAGENT FOR EARLY DIAGNOSIS ANDOR PROGNOSIS OF ALZHEIMER DISEASE USE OF IGF AS A REAGENT FOR EARLY DIAGNOSIS ANDOR PROGNOSIS OF ALZHEIMER DISEASE
Use of iminocyclitols as inhibitors of bacterial adherence to epithelial cells Use of iminocyclitols as inhibitors of bacterial adherence to epithelial cells
USE OF INDUCTOR AGENTS GSE242 FOR PRODUCING PHARMACEUTICAL COMPOSITIONS FOR TREATING ILLNESSESS RELATING TO CELLULAR SENESCENCE USE OF INDUCTOR AGENTS GSE242 FOR PRODUCING PHARMACEUTICAL COMPOSITIONS FOR TREATING ILLNESSESS RELATING TO CELLULAR SENESCENCE
USE OF INDUCTOR AGENTS GSE242 FOR PRODUCING PHARMACEUTICAL COMPOSITIONS FOR TREATING ILLNESSESS RELATING TO CELLULAR SENESCENCE USE OF INDUCTOR AGENTS GSE242 FOR PRODUCING PHARMACEUTICAL COMPOSITIONS FOR TREATING ILLNESSESS RELATING TO CELLULAR SENESCENCE